Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBT Margin (2020 - 2025)

Historic EBT Margin for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to 25.7%.

  • PROCEPT BioRobotics' EBT Margin rose 102400.0% to 25.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.2%, marking a year-over-year increase of 218700.0%. This contributed to the annual value of 40.72% for FY2024, which is 370400.0% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' EBT Margin stood at 25.7%, which was up 102400.0% from 24.73% recorded in Q2 2025.
  • Over the past 5 years, PROCEPT BioRobotics' EBT Margin peaked at 24.73% during Q2 2025, and registered a low of 180.98% during Q4 2021.
  • Moreover, its 5-year median value for EBT Margin was 76.38% (2023), whereas its average is 90.96%.
  • As far as peak fluctuations go, PROCEPT BioRobotics' EBT Margin surged by 4072100bps in 2021, and later soared by 43300bps in 2023.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' EBT Margin stood at 180.98% in 2021, then surged by 42bps to 104.78% in 2022, then surged by 40bps to 63.11% in 2023, then soared by 56bps to 27.63% in 2024, then grew by 7bps to 25.7% in 2025.
  • Its last three reported values are 25.7% in Q3 2025, 24.73% for Q2 2025, and 35.77% during Q1 2025.